Dr. Eugenio Rocksmith, co-director of the Traumatic Brain Injury Rehabilitation Program, and Dr. Jacqueline Weaver, Clinical Neuropsychologist, are about to join a multicenter clinical trial on the safety and efficacy of a novel pharmacologic medication for the treatment of neurobehavioral disinhibition in outpatients with traumatic brain injury.

Please check back for updates on TBI work.